Lillicrap DP - Search Results

1

Riddel JP Jr, Aouizerat BE, Miaskowski C, Lillicrap DP. Riddel JP Jr, et al. Among authors: lillicrap dp. J Pediatr Oncol Nurs. 2007 May-Jun;24(3):123-31. doi: 10.1177/1043454206298693. J Pediatr Oncol Nurs. 2007. PMID: 17475978 Review.

2

Gene Therapy for Coagulation Disorders.

Swystun LL, Lillicrap D. Swystun LL, et al. Circ Res. 2016 Apr 29;118(9):1443-52. doi: 10.1161/CIRCRESAHA.115.307015. Circ Res. 2016. PMID: 27126652 Review.

3

Coagulation factors--molecular attributes and their clinical impact.

Kamphuisen PW, Lillicrap D. Kamphuisen PW, et al. Thromb Res. 2008;122 Suppl 4:S1. doi: 10.1016/S0049-3848(08)70026-4. Thromb Res. 2008. PMID: 18929520 No abstract available.

4

The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels.

Rydz N, Swystun LL, Notley C, Paterson AD, Riches JJ, Sponagle K, Boonyawat B, Montgomery RR, James PD, Lillicrap D. Rydz N, et al. Blood. 2013 Jun 27;121(26):5228-37. doi: 10.1182/blood-2012-10-457507. Epub 2013 Mar 25. Blood. 2013. PMID: 23529928 Free PMC article.

5

FVIII stabilization: VWF D'D3 will do.

Swystun LL, Lillicrap D. Swystun LL, et al. Blood. 2014 Jul 17;124(3):313-5. doi: 10.1182/blood-2014-06-578955. Blood. 2014. PMID: 25035147 Free article.

6

How much do we really know about von Willebrand disease?

Swystun LL, Lillicrap D. Swystun LL, et al. Curr Opin Hematol. 2016 Sep;23(5):471-8. doi: 10.1097/MOH.0000000000000272. Curr Opin Hematol. 2016. PMID: 27428891 Review.

7

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation.

Michels A, Swystun LL, Mewburn J, Albánez S, Lillicrap D. Michels A, et al. J Vis Exp. 2017 Aug 14;(126):55917. doi: 10.3791/55917. J Vis Exp. 2017. PMID: 28829426 Free PMC article.

8

The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance.

Mufti AH, Ogiwara K, Swystun LL, Eikenboom JCJ, Budde U, Hopman WM, Halldén C, Goudemand J, Peake IR, Goodeve AC, Lillicrap D, Hampshire DJ; European Group on von Willebrand disease (EU-VWD) and Zimmerman Program for the Molecular and Clinical Biology of von Willebrand disease (ZPMCB-VWD) Study Groups. Mufti AH, et al. Blood Adv. 2018 Jul 10;2(13):1585-1594. doi: 10.1182/bloodadvances.2017011643. Blood Adv. 2018. PMID: 29980574 Free PMC article.

9

N-linked glycosylation modulates the immunogenicity of recombinant human factor VIII in hemophilia A mice.

Lai JD, Swystun LL, Cartier D, Nesbitt K, Zhang C, Hough C, Dennis JW, Lillicrap D. Lai JD, et al. Haematologica. 2018 Nov;103(11):1925-1936. doi: 10.3324/haematol.2018.188219. Epub 2018 Jul 12. Haematologica. 2018. PMID: 30002126 Free PMC article.

10

The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity.

Swystun LL, Lai JD, Notley C, Georgescu I, Paine AS, Mewburn J, Nesbitt K, Schledzewski K, Géraud C, Kzhyshkowska J, Goerdt S, Hopman W, Montgomery RR, James PD, Lillicrap D. Swystun LL, et al. J Clin Invest. 2018 Aug 31;128(9):4057-4073. doi: 10.1172/JCI96400. Epub 2018 Aug 20. J Clin Invest. 2018. PMID: 30124466 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters